p53-Encoding pDNA Purification by Affinity Chromatography for Cancer Therapy

Area of Science:

• Molecular Biology
• Biotechnology
• Cancer Research

Background:

• The p53 tumor suppressor is crucial for preventing malignant cell transformation.
• Effective gene therapy relies on efficient gene transfer, which is influenced by vector manufacturing.
• High-purity supercoiled plasmid DNA is essential for pharmaceutical applications.

Purpose of the Study:

• To describe a method for preparing and purifying supercoiled plasmid DNA to meet regulatory standards.
• To evaluate the efficacy of arginine affinity chromatography for plasmid DNA purification.
• To demonstrate the biological activity of purified plasmid DNA in cancer cell lines.

Main Methods:

• Utilized arginine affinity chromatography for plasmid DNA purification.
• Developed detailed procedures for downstream processing of plasmid DNA.
• Assessed the purity and quality of the supercoiled plasmid DNA.

Main Results:

• Achieved pharmaceutical-grade purity of supercoiled plasmid DNA.
• The purified plasmid DNA demonstrated efficient transfection in eukaryotic cells.
• Restoration of p53 protein levels was observed in treated cancer cell lines.

Conclusions:

• Arginine affinity chromatography is a viable method for producing high-purity plasmid DNA.
• The purified plasmid DNA is biologically active and suitable for gene therapy applications.
• This approach offers a promising strategy for effective anticancer treatment through p53 reestablishment.